Risk of Nephrogenic Systemic Fibrosis in Patients With Stage 4 or 5 Chronic Kidney Disease Receiving a Group II Gadolinium-Based Contrast Agent

出版年份 2019 全文链接

标题

作者

关键词

出版物

Volume 180, Issue 2, Pages 223

出版商

American Medical Association (AMA)

发表日期

2019-12-10

DOI

10.1001/jamainternmed.2019.5284

Explore over 38,000 international journals covering a vast array of academic fields.

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now